The CEO of a pharmaceutical consultations company is ready for discussions about the potential sale of his company. This opportunity can be interesting for a global pharma company with plans to enter the European market by acquisitions. The company owns all necessary pharmaceutical manufacturing licenses for Europe and Germany, which can be of high value for a potential acquirer. The company is young and dynamic and is on its way to further growth.
The owner and CEO of a successful GMP compliant pharmaceutical company with offices in the EU and the USA have asked us to help him with the sale of his company.
The company for sale was incorporated approximately three years ago and has already earned a manufacturer’s authorization. The company is run by its founding partners. The staff of the company has on average 30+ years of experience in the pharmaceutical industry and have produced and released 1000s of batches of pharmaceutical products.
The company has already set up an affiliate office in EU with a manufacturer’s authorization and another office in the U.S. The company employs many qualified people (QP/FvP) as well as CMC and regulatory staff.
The turnover after the first phase of the company is in the range of 2-3M EUR. The EBITDA is not at its potential levels, due to the startup phase of the company and lots of investments, but the future numbers were estimated to be much better in coming years.
The owner is looking out for an opportunity of a collaboration with larger pharma company or trade-sale of the group of companies.
Contact us to get details about this pharmaceutical consultancy company in Germany for sale
The company for sale is a certified GMP manufacturer and is allowed to manufacture, import, export, distribute, and sell pharmaceutical products. The company is an independent consulting company, and it is expanding rapidly in the region. The company is able to help its clients with
The value of the company lies mainly in the possibility for a pharmaceutical partner outside of Europe to get immediate access to the EU and US market for pharmaceutical products. Also, the company has a very experienced team, with manufacturer’s authorization to develop, manufacture, release, and distribute pharmaceutical products, which can be of great benefit to the acquirer.
The company also uses an exceptional tax arrangement that enables the company to lower the effective tax rate on profits of the company. The business plan of the company projects the turnover and EBITDA of the company to grow steadily after acquisition and investments in the growth.
Please feel free to ask for more information about this pharmaceutical consultancy company in Germany for sale. If this company does not match your preferences, ask for our other pharmaceutical companies open for a sale. We know the pharmaceutical industry. If you are looking for other pharmaceutical business for sale, please visit the section pharmaceutical companies for sale. If you are looking to sell your pharmaceutical business or you know about the pharmaceutical company for sale, please visit the section pharmaceutical companies wanted. Also, if you are interested in companies in Western Europe or Germany, you can look at our section companies in Germany for sale.
Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company, we assess the likelihood of a future transaction. We only get back to you if we see a realistic opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual, please explain as much as possible about your personal background, strategy and fit with the target. There is also a possibility that your details will be kept on file and we will get back to you once there is an opportunity to do a transaction. CFIE can’t guarantee you will receive an answer to your request.